Ivermectin

伊维菌素

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameIvermectin
Drug Alias Name伊佛霉素ivermectina伊维霉素ivermectinum依维菌素 +[19] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate-gated chloride channel modulators
TargetsGlutamate-gated chloride channel
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursAlcoholism +[25] 
Global Approved IndicationsHookworm InfectionsOnchocerciasisElephantiasis, Filarial +[8] 
Approved Indications in ChinaHookworm InfectionsOnchocerciasisElephantiasis, Filarial +[8] 
Original Approved Country/TerritoryUnited States
Original Approved Date1996/11/22
Country/TerritoryCzechiaBulgariaCanada +[35] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesKowa Company LtdHumanis Saglık Anonim SirketiArbor Pharmaceuticals Llc +[16] 
Inactive CompaniesUniversidad De San SimonInvestigacion Biomedica Para El Desarrollo De Farmacos S.A De CvUniversidade Federal De Sao Carlos +[42] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumoursRosacea +[16] 
Inactive IndicationsAlcoholismLichen PlanusAcne Vulgaris +[9] 

Other Information

ATC CodeD11AX22P02CF01
Related LinksWikipediaDrugBankKEGG